Concurrent publication in the journal Cancer Discovery highlights NST-628's differentiated mechanism and preclinical activity across diverse KRAS-, NRAS-, and BRAF-driven tumors Phase 1 study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback